Cargando…
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database
Multiple myeloma therapy has made remarkable progress with the advent of new drugs. We explored the treatment pattern and outcomes in Japanese patients with multiple myeloma using the Medical Data Vision database. Patients were categorized as per the initial diagnosis period (2003–2015 and 2016–2020...
Autores principales: | Handa, Hiroshi, Ishida, Tadao, Ozaki, Shuji, Mori, Asuka, Kato, Kenichi, Iida, Shinsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079007/ https://www.ncbi.nlm.nih.gov/pubmed/37023056 http://dx.doi.org/10.1371/journal.pone.0283931 |
Ejemplares similares
-
Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in Japan
por: Suzuki, Kenshi, et al.
Publicado: (2017) -
Risk factors associated with overall survival in patients with multiple myeloma following carfilzomib treatment: A retrospective study from a large claims database in Japan
por: Hagiwara, Hiromi, et al.
Publicado: (2023) -
Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database
por: Ishida, Takayuki, et al.
Publicado: (2018) -
Multikinase Inhibitor Treatment Patterns for Advanced Thyroid Cancer in Japan: An Administrative Claims Database Study
por: Masaki, Chie, et al.
Publicado: (2022) -
Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR
por: Takezako, Naoki, et al.
Publicado: (2020)